Valproate administration has also been shown to trigger acute hyperammonemia in patients with no underlying metabolic issues, and to unmask OTC deficiency in heterozygous females [18, 19, 20]. This evidence concerns the gene OTC and hyperinsulinemic hypoglycemia, familial, 4.